Loading
RI
Receptos, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by MAST ERLE T, was filed 18 Mar 2014.
Receptos, Inc.: what insiders have been doing
Receptos, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Receptos, Inc. has published a filing in the past twelve months. The most recent one dates from 27 August 2015.
Our records for Receptos, Inc. go back to 2013, with 8 purchases and 64 sales on the open market in total.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
162
Thresholds
n/a
Buy Volume
€11M
8 ops. · all time
Sell Volume
€149M
64 ops. · all time
Last declaration on 27 August 2015
Declarations162 total
7,400 sharesCommon StockSEC:0000899243-15-004157:1
19,632 sharesCommon StockSEC:0000899243-15-004147:0
316,908 sharesCommon StockSEC:0000899243-15-004147:1
18,346 sharesCommon StockSEC:0000899243-15-004147:2
7,400 sharesCommon StockSEC:0000899243-15-004147:3
300 sharesCommon StockSEC:0000899243-15-004155:0
665,561 sharesCommon StockSEC:0000899243-15-004156:0
7,400 sharesCommon StockSEC:0000899243-15-004156:1
7,400 sharesCommon StockSEC:0000899243-15-004155:1
131,297 sharesCommon StockSEC:0000899243-15-004151:0
7,000 sharesCommon StockSEC:0000899243-15-004151:1
7,400 sharesCommon StockSEC:0000899243-15-004148:0
7,400 sharesCommon StockSEC:0000899243-15-004152:0
10,500 sharesCommon StockSEC:0000899243-15-004153:0
104,692 sharesCommon StockSEC:0000899243-15-004150:0
7,000 sharesCommon StockSEC:0000899243-15-004150:1
9,500 sharesCommon StockSEC:0000899243-15-004149:0
332,234 sharesCommon StockSEC:0000899243-15-004157:0
120,661 sharesCommon StockSEC:0000899243-15-004158:0
12,500 sharesCommon StockSEC:0000899243-15-004158:1
145,656 sharesCommon StockSEC:0000899243-15-004143:0
7,000 sharesCommon StockSEC:0000899243-15-004143:1
384,409 sharesCommon StockSEC:0000899243-15-004140:0
32,500 sharesCommon StockSEC:0000899243-15-004140:1
7,400 sharesCommon StockSEC:0000899243-15-004146:0
25 of 162 declarations
About Receptos, Inc.
Receptos, Inc. is a biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases. It was acquired by Celgene Corporation in 2015.
